Overview

A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin

Status:
Completed
Trial end date:
2000-06-08
Target enrollment:
Participant gender:
Summary
This trial was conducted in the United States of America (USA). The aim of this clinical trial was to investigate the pharmacokinetics of somatropin in healthy Japanese and Caucasian subjects, and to identify somatostatin-related adverse events.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S